Morning Overview on MSN
FDA clears first US trial of Motif’s wireless brain implant for depression
A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest regulatory hurdle. In late April 2026, the FDA granted Motif Neurotech an ...
The deployment of Large Language Models (LLMs) on edge devices represents a paradigm shift in artificial intelligence, ...
The development of artificial intelligence-generated content (AIGC) technology brings new opportunities for the teaching reform of basic courses in colleges and universities. Based on the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results